Peridialysis Project: The Influence of Predialysis Factors on the Initial Course of Dialysis (Peridialysis)
The present study plans to delineate the clinical, biochemical, sociological and psychological factors. involved in dialysis preparation, and their impact on dialysis initiation (DI), modality choice and prognosis. In particular the following questions are to be answered.
- What factors influence unplanned DI?
- What factors influence choice of dialysis modality?
- What factors influence choice of dialysis access?
- Why do physicians start dialysis?
- What factors in the predialytic period and its immediate aftermath (the "peridialytic" period) influence prognosis?
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Patients All patients starting active end stage renal disease (ESRD) treatment at the participating centres and their satellite centres.
No. Patients: 1000.
- Patients who have received their recent predialysis care at another centre can be included if the previous centre's notes are available, otherwise not.
- Patients receiving a preemptive transplant are included, even if the transplant is performed at another centre. A patient questionnaire is not required for these patients.
- Africans are excluded (inaccurate estimated glomerular filtration rate (eGFR) calculation) Each patient is allocated a local identity number (1,2,3….). The local author keeps a registry of the true patient identity of each identity number for follow-up purposes. This registry is not to be used in any communication outside the centre.
Comment: Most patients have known chronic uremia at dialysis start. In a few cases, it is unknown whether the uremia is acute or chronic. There are two main groups:
- Acute uremia of unknown origin. Doctors should fill the questionnaire in Table 2, which can be discarded if the patient recovers renal function within three months.
- Acute kidney injury (AKI). Most of these patients will recover within three months, so the questionnaire can wait, and be filled in retrospectively for the few remaining patients.
Methods
- Each participating centre fills a Centre Questionnaire, see Table 1.
- All prescribing doctors fill in a voluntary Physician Questionnaire, see Table 4.
- The doctor prescribing the first dialysis fills in a Motivation Questionnaire, see Table 2.
The local coordinator fills in a Patient Notes Review
- Birthday
- Sex
- Height and weight
- Renal diagnosis
- Comorbidity
- Date and creatinine at referral to nephrology dept.
- Date and creatinine 6 months before dialysis start
- Date and creatinine 3 months before dialysis start
- Date and creatinine at start of dialysis information/choice
- Date and creatinine at access prescription. Date and creatinine at access creation. If there are several attempts at access creation, the last attempt is registered. For unplanned dialysis start, this is often the same date as dialysis start.
- Date of dialysis start
- Following values before first dialysis: B-hemoglobin, p- creatinine, urea, potassium, calcium, phosphate, bicarbonate, albumin
- Initial dialysis modality (centre hemodialysis (HD)/Home HD/continuous ambulatory peritoneal dialysis (CAPD)/ automated peritoneal dialysis (APD))
- Type of start (Planned/unplanned)
- Reason for unplanned start (primary and (if appropriate) secondary).
- For hemodialysis patient (HD) patients, initial access (areteriovenous fisula (AVF)/arteriovenous graft (AVG) /tunneled central venous catheter (CVC)/temporary CVC)
- Modality after 3 months (Center HD/Home HD/CAPD/APD/regained function/Transplanted/Dead)
- Is the patient alive after 3 months Yes/No. If "No" Date of death.
- Is the patient alive after 6 months Yes/No.
- If "No" Date of death.Is the patient alive after 12 months Yes/No. If "No" Date of death.
- Was the patient transplanted after inclusion? If so, when?
Responsibilities National coordinators are responsible for translation of protocol to local language, and compliance with any necessary national regulatory requirements (data protection agency, ethical committee?) Local representatives: local coordination and follow-up. Patient notes review. Additional secretarial assistance, paid or unpaid, is permitted.
Definitions
ESRD
A patient has ESRD if any of the following:
- He receives a transplant
- The doctor "believes" that he has ESRD at first dialysis
- He has received >90 days dialysis
- If the doctor is in doubt whether the patient has acute or chronic renal failure, the patient is registered as soon as there is no doubt that the patient has ESRD For 3 & 4, registration is performed retrospectively from the first dialysis day.
Planned dialysis
The patient's first dialysis is planned if:
- His first hemodialysis uses an AV fistula
- His first hemodialysis uses a permanent catheter as the patient's permanent access
- His first peritoneal dialysis is >6 days after catheter placement.
The patient's first dialysis is unplanned if:
- His first hemodialysis uses a temporary catheter
- His first hemodialysis uses a permanent catheter as the patient's temporary access (i.e. a later AV fistula is planned.
- His first peritoneal dialysis is <7 days after catheter placement.
Renal Diagnoses
- Shrunken Kidneys of unknown cause
- Glomerulonephritis
- Chronic interstitial nephropathy, chronic pyelonephritis and postrenal uremia
- Polycystic kidney disease
- Hypertensive/atherosclerotic renal disease
- Diabetic Nephropathy
- Other
Causes of unplanned dialysis
- Late referral
- Acute uremia
- Acute progression of chronic uremia
- Doubt about reversibility
- Clinical indication despite acceptable biochemistry
- Fistula problems
- Delayed planning (Controversial. I recommend dialysis planning at the latest when eGFR <15 ml/minute. Please use your own definition).
- Patient non-compliance
- Patient refused dialysis, but later changed his/her mind
Causes of PD modality
- Patient choice
- Cardiac insufficiency
- HD not possible
Causes of HD Modality
- Patient Choice
- Physically incapable of peritoneal dialysis (PD)
- Mentally incapable of PD
- Abdominal problems
- Wish for Home HD
- PD not considered
Table 1 Center Questionnaire
- Author:
- Centre Name:
- Centre type: University/Non-academic
- Approximate population covered:
- No. new ESRD patients/year
How many of these
- Preemptive transplant (%)?
- PD (%)?
- HD (%)?
What is the
- PD prevalence (no. patients)?
- HD prevalence?
- How many nephrology specialists?
Does the department have an official policy concerning preferred initial modality:
- No
- PD first
- Home HD first
- Other (what?)
- Does the department have an official policy concerning when pretransplant investigations should be initiated? If so what? If not, is there unofficial consensus? What?
- Does the department have an official policy concerning when dialysis modality choice is made? If so what? If not, is there unofficial consensus? What?
- Does the department have an official policy concerning when AV fistulae/grafts are prescribed? If so what? If not, is there unofficial consensus? What?
- Does the department have an official policy concerning when peritoneal dialysis catheters are prescribed? If so what? If not, is there unofficial consensus? What?
- Does the department have an official policy concerning when chronic dialysis is prescribed? If so what? If not, is there unofficial consensus? What?
Table 2. Motivation Questionnaire
You have just prescribed this patient's first dialysis. If you do not believe that the patient's dialysis requirement is chronic, you do not have to fill in this form Put a "1" besides the primary reason for starting dialysis today. Put a "2" besides a (possible) secondary reason for starting dialysis today. Put a "X" besides any other reasons that have been important in influencing your decision to prescribe dialysis today.
Taste disturbances Pulmonary stasis Social (what?) Dyspnea Practical (what?) (e.g. catheter protection) Hypertension Pericarditis Oedema Biochemical Cardiac symptoms High Plasma-Creatinine Fatigue High Urea Anorexia Low glomerular filtration rate (GFR) Nausea/vomiting High Potassium Cachexia/weight loss Acidosis Itching Low calcium Insomnia High Calcium Depression High Phosphate Diarrhea Falling GFR Other (what?)
Table 4. Physician Questionnaire What is your age? What is your sex? Are you a nephrology specialist? How many years have you been a doctor? How many years have you been a nephrology specialist?
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: James G Heaf, MD DMSc
- Phone Number: +4535125361
- Email: heaf@dadlnet.dk
Study Locations
-
-
-
Herlev, Denmark, 2730
- Recruiting
- Herlev Hospital
-
Contact:
- James G Heaf, MD DMSc
- Phone Number: +4535125361
- Email: heaf@dadlnet.dk
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- All patients starting maintenance dialysis therapies at the participating centers
Exclusion Criteria:
- Africans
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Proportion of patients who start planned dialysis initiation as defined by the protocol
Time Frame: 1 year
|
Planned dialysis The patient's first dialysis is planned if:
The patient's first dialysis is unplanned if:
|
1 year
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Death
Time Frame: 1 year
|
Time to patient death
|
1 year
|
|
Choice of dialysis modality
Time Frame: 1 year
|
Centre HD, Home HD, CAPD or APD
|
1 year
|
|
Choice of dialysis access
Time Frame: 1 year
|
AVF, AVG, Temporary CVC, Tunneled CVC, or PD catheter
|
1 year
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (ANTICIPATED)
Primary Completion
Study Completion (ANTICIPATED)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
First Posted
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- CRU ID 15002474
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on End Stage Renal Disease
-
NCT04912050CompletedAcute Kidney Injury | End Stage Renal Disease (ESRD) | End Stage Renal Disease on Dialysis
-
NCT01691196WithdrawnObesity | End-Stage Renal Disease | Renal Disease, End-Stage | Renal Failure, End-Stage
-
NCT01921933CompletedEnd-stage Renal Disease | End-stage Kidney Disease
-
NCT07538687Not yet recruitingEnd Stage Renal Disease on Dialysis
-
NCT07201467RecruitingEnd-Stage Renal Disease Requiring Haemodialysis
-
NCT06842927Enrolling by invitationDialysis Efficiency and Transporter Evaluation Computational Tool in Peritoneal Dialysis (DETECT-PD)Peritoneal Dialysis | End-Stage Kidney Disease | End Stage Renal Disease (ESRD) | End Stage Renal Failure on Dialysis | Peritoneal Dialysis Patients | End Stage Renal Disease on Dialysis (Diagnosis)
-
NCT00858182WithdrawnEnd-Stage Renal Disease
-
NCT00490737Completed
-
NCT02568891WithdrawnEnd-stage Renal Disease
-
NCT02289703Completed
Clinical Trials on No intervention
-
NCT06980844Not yet recruitingInterstitial Lung Disease
-
NCT02746445Completed
-
NCT05345054CompletedInflammatory Bowel Diseases | Colorectal Cancer | Diverticular Diseases | Social Behavior
-
NCT01923415CompletedLupus Erythematosus, Systemic | Lupus Erythematosus, Cutaneous | Lupus Erythematosus, Discoid
-
NCT06686342RecruitingHead and Neck Squamous Cell Carcinoma | Patient Derived Organoid | Drug Sensitive Test in Vitro
-
NCT06134739RecruitingEmbolism | Atrial Fibrillation | Arrhythmia | Stroke, Acute | Stroke Sequelae | Ablation
-
NCT03305484CompletedContact Lens Complication | Contact Lens Acute Red Eye | Contact Lens Related Corneal Infiltrate (Disorder) | Contact Lens-Induced Corneal Fluorescein Staining
-
NCT04490811Unknown